awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36603276-D6A56FF2-E56D-4C0B-ABD0-2B3E80E9221E
Q36603276-D6A56FF2-E56D-4C0B-ABD0-2B3E80E9221E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36603276-D6A56FF2-E56D-4C0B-ABD0-2B3E80E9221E
Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study.
P2860
Q36603276-D6A56FF2-E56D-4C0B-ABD0-2B3E80E9221E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36603276-D6A56FF2-E56D-4C0B-ABD0-2B3E80E9221E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3f172abac7d6285a54f911994554cdb745ca98cf
P2860
Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study.